Delta-1 enhances marrow and thymus repopulating ability of human CD34+CD38- cord blood cells

Journal of Clinical Investigation

Volumn 110, Issue 8, 2002, Pages 1165-1174

  Ohishi, Kohshi ^a   Varnum Finney, Barbara ^a   Bernstein, Irwin D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 7; LIGAND; MESSENGER RNA; NOTCH LIGAND DELTA 1; NOTCH RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMUS; UMBILICAL CORD BLOOD;

EID: 0036802174     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0216167     Document Type: Article

References (43)

1. Ogawa, M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood. 81:2844-2853.
2. Artavanis-Tsakonas, S., Rand, M.D., and Lake, R.J. 1999. Notch signaling: Cell fate control and signal integration in development. Science. 284:770-776.
3. Karanu, F.N., et al. 2000. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192:1365-1372.
4. Ohishi, K., et al. 2000. Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood. 95:2847-2854.
5. Milner, L.A., Kopan, R., Martin, D.I., and Bernstein, I.D. 1994. A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors. Blood. 83:2057-2062.
6. Karanu, F.N., et al. 2001. Human homologues of Delta-1 and Delta-4 function as mitogenic regulators of primitive human hematopoietic cells. Blood. 97:1960-1967.
7. Jones, P., et al. 1998. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood. 92:1505-1511.
8. Li, L., et al. 1998. The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch 1. Immunity. 8:43-55.
9. Varnum-Finney, B., et al. 2000. Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive Notch1 signaling. Nat. Med. 6:1278-1281.
10. Stier, S., Cheng, T., Dombkowski, D., Carlesso, N., and Scadden, D. 2002. Notch1 activation increases hematopoietic stem cell self-renewal in vivo and favors lymphoid over myeloid lineage outcome. Blood. 99:2369-2378.
11. Carlesso, N., Aster, J.C., Sklar, J., and Scadden, D.T. 1999. Notch1-induced delay of human hematopoietic progenitor cell differentiation is associated with altered cell cycle kinetics. Blood. 93:838-848.
12. Han, W., Ye, Q., and Moore, M.A. 2000. A soluble form of human Delta-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood. 95:1616-1625.
13. Tsai, S., Fero, J., and Bartelmez, S. 2000. Mouse Jagged2 is differentially expressed in hematopoietic progenitors and endothelial cells and promotes the survival and proliferation of hematopoietic progenitors by direct cell-to-cell contact. Blood. 96:950-957.
14. Varnum-Finney, B., et al. 1998. The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood. 91:4084-4091.
15. Jaleco, A.C., et al. 2001. Differential effects of notch ligands delta-1 and jagged-1 in human lymphoid differentiation. J. Exp. Med. 194:991-1002.
16. Walker, L., et al. 1999. The Notch/Jagged pathway inhibits proliferation of human hematopoietic progenitors in vitro. Stem Cells. 17:162-171.
17. Allman, D., et al. 2001. Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J. Exp. Med. 194:99-106.
18. Wilson, A., MacDonald, H.R., and Radtke, F. 2001. Notch 1-deficient common lymphoid precursors adopt a B cell fate in the thymus. J. Exp. Med. 194:1003-1012.
19. Radtke, F., et al. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 10:547-558.
20. Pui, J.C., et al. 1999. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity. 11:299-308.
21. Varnum-Finney, B., et al. 2000. Immobilization of Notch ligand, Delta-1, is required for induction of notch signaling. J. Cell Sci. 113:4313-4318.
22. Ohishi, K., Varnum-Finney, B., Serda, R.E., Anasetti, C., and Bernstein, I.D. 2001. The Notch ligand, Delta-1, inhibits the differentiation of monocytes into macrophages but permits their differentiation into dendritic cells. Blood. 98:1402-1407.
23. Levelt, C.N., and Eichmann, K. 1994. Streptavidin-tricolor is a reliable marker for nonviable cells subjected to permeabilization or fixation. Cytometry. 15:84-86.
24. Gaffney, P.M., Lund, J., and Miller, J.S. 1998. FLT-3 ligand and marrow stroma-derived factors promote CD3gamma, CD3delta, CD3zeta, and RAG-2 gene expression in primary human CD34+LIN-DR-marrow progenitors. Blood. 91:1662-1670.
25. Ramsfjell, V., et al. 1999. Distinct requirements for optimal growth and in vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-1C), extended LTC-1C, and murine in vivo long-term reconstituting stem cells. Blood. 94:4093-4102.
26. Zandstra, P.W., Conneally, E., Petzer, A.L., Piret, J.M., and Eaves, C.J. 1997. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc. Natl. Acad. Sci. USA. 94:4698-4703.
27. Robetamanith, T., et al. 2001. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells. Stem Cells. 19:313-320.
28. Bhatia, M., et al. 1997. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186:619-624.
29. Dao, M.A., Hashino, K., Kato, I., and Nolta, J.A. 1998. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood. 92:4612-4621.
30. Kuroda, K., et al. 1999. Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis. J. Biol. Chem. 274:7238-7244.
31. Jarriault, S., et al. 1998. Delta-1 activation of Notch-1 signaling results in HES-1 transactivation. Mol. Cell. Biol. 18:7423-7431.
32. Piacibello, W., et al. 1999. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells. Blood. 93:3736-3749.
33. Hao, Q.L., et al. 2001. Identification of a novel, human multilymphoid progenitor in cord blood. Blood. 97:3683-3690.
34. Canque, B., et al. 2000. Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells. Blood. 96:3748-3756.
35. Plum, J., et al. 1999. In vitro intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split. J. Immunol. 162:60-68.
36. Sanchez, M.J., Muench, M.O., Roncarolo, M.G., Lanier, L.L., and Phillips, J.H. 1994. Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180:569-576.
37. Bertrand, F.E., et al. 2000. Microenvironmental influences on human B-cell development. Immunol. Rev. 175:175-186.
38. Plum, J., De Smedt, M., Leclercq, G., Verhasselt, B., and Vandekerckhove, B. 1996. Interleukin-7 is a critical growth factor in early human T-cell development. Blood. 88:4239-4245.
39. Glimm, H., et al. 2001. Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice. J. Clin. Invest. 107:199-206.
40. Robin, C., Pflumio, F., Vainchenker, W., and Coulombel, L. 1999. Identification of lymphomyeloid primitive progenitor cells in fresh human cord blood and in the marrow of nonobese diabetic-severe combined immunodeficient (NOD-SCID) mice transplanted with human CD34(+) cord blood cells. J. Exp. Med. 189:1601-1610.
41. Miller, J.S., McCullar, V., Punzel, M., Lemischka, I.R., and Moore, K.A. 1999. Single adult human CD34(+)/Lin-/CD38(-) progenitors give rise to natural killer cells, B-lineage cells, dendritic cells, and myeloid cells. Blood. 93:96-106.
42. Gluckman, E. 2001. Hematopoietic stem-cell transplants using umbilical-cord blood. N. Engl. J. Med. 344:1860-1861.
43. Laughlin, M.J., et al. 2001. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N. Engl. J. Med. 344:1815-1822.